Literature DB >> 2501627

Quality-adjusted life years, utility theory, and healthy-years equivalents.

A Mehrez1, A Gafni.   

Abstract

Decisions about medical treatments and the settings of health programs are not purely technical, but also involve issues of value such as the evaluation of trade-offs between quality of life (morbidity) and quantity of life (mortality). The most commonly used measure of outcome in such cases is the quality-adjusted life year (QALY). The authors show that QALYs, being a health status index, do not stem directly from the individual's utility function and thus only partly reflect the individual's true preferences. This might lead to the choice of the nonpreferred alternative due to the misrepresentation of the individual's preferences. Two examples illustrate this claim. An alternative measure of outcome, the healthy-years equivalent (HYE), is described. This measure stems directly from the individual's utility function and thus fully reflects his/her preferences. It combines outcomes of both morbidity and mortality and thus can serve as common unit of measure for all programs, allowing comparisons across programs. Different ways of measuring the HYE are discussed.

Keywords:  Empirical Approach; Health Care and Public Health

Mesh:

Year:  1989        PMID: 2501627     DOI: 10.1177/0272989X8900900209

Source DB:  PubMed          Journal:  Med Decis Making        ISSN: 0272-989X            Impact factor:   2.583


  73 in total

1.  QALYs and the integration of claims in health-care rationing.

Authors:  P Anand
Journal:  Health Care Anal       Date:  1999

2.  Bridging decision analytic modelling with a cross-sectional study. Application to Parkinson's disease.

Authors:  M J Nuijten
Journal:  Pharmacoeconomics       Date:  2000-03       Impact factor: 4.981

Review 3.  Handling uncertainty in cost-effectiveness models.

Authors:  A H Briggs
Journal:  Pharmacoeconomics       Date:  2000-05       Impact factor: 4.981

Review 4.  A review of alternative approaches to healthcare resource allocation.

Authors:  S Petrou; J Wolstenholme
Journal:  Pharmacoeconomics       Date:  2000-07       Impact factor: 4.981

Review 5.  Valuing health-related quality of life. Issues and controversies.

Authors:  P Dolan
Journal:  Pharmacoeconomics       Date:  1999-02       Impact factor: 4.981

6.  Reporting format for economic evaluation. Part I: Application to the Dutch healthcare system.

Authors:  M J Nuijten; M J Brorens; Y A Hekster; A van der Kuy; J H Lockefeer; P A de Smet; G Bonsel; M H Pronk
Journal:  Pharmacoeconomics       Date:  1998-08       Impact factor: 4.981

7.  Measurement of short term health effects in economic evaluations.

Authors:  A M Holmes
Journal:  Pharmacoeconomics       Date:  1998-02       Impact factor: 4.981

8.  Efficient use of health care resources: the interaction between improved health and reduced health related income loss.

Authors:  Michael Hoel
Journal:  Int J Health Care Finance Econ       Date:  2002-11

Review 9.  Resource allocation, social values and the QALY: a review of the debate and empirical evidence.

Authors:  David L B Schwappach
Journal:  Health Expect       Date:  2002-09       Impact factor: 3.377

10.  Studying patients' preferences in health care decision making. Health Services Research Group.

Authors: 
Journal:  CMAJ       Date:  1992-09-15       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.